Hope For Animals - Cancer Cure Inside Scorpion Venom
12/06/2014 11:33
https://www.petlifepharma.com/
Yes, it is actually indeed being talked about, and the customer feedback that are pouring in in. The Blue Scorpion venom is getting extracted, infused and inserted, named Escozine, trademarked through Medolife, and one such other company is creating a product for the other loved ones in our life, our cats and dogs. PetLife Pharmaceuticals (ticker PTLF) is in fact introducing Escozine For Pets, for animals with assorted stages of cancer and through the preliminary test findings, it appears to be highly exciting. Based on some research studies, CNN article being one, cancer may be the top killer in approximately Fifteen years, exceeding heart disease and we are in critical necessity of some alternative therapies. Escozine meets the balance of in between organic and conventional therapy and for those without much hope or response coming from traditional treatments, Esconzine is deserving of plenty of interest.
Escozine For Pets could be purchased straight from the provider's website - https://www.petlifepharma.com/
Escozine™ was in fact previously created and commercialized by Medolife Corp. in '07. Medolife at the moment retains the exclusive patent license for the human usages, of the bioactive peptide and polarization technologies used to create the Polarized Dilute Blue Scorpion Venom. In 2014, the patent owner, Arthur Grant Mikaelian, approved an exclusive worldwide authorization intended for production, marketing and advertising and sales to PetLife, for veterinarian usages of Escozine for Pets™, including the nutraceutical as well as future Approved by the FDA versions.
Escozine™ -- The Breakthrough in Cancer Treatment and Prevention
In 2012, University of California San Diego, Moores Cancer Center, together with Medolife Corp.) carried out research applying polarized dilute Blue Scorpion venom utilizing the Mikaelian's patented process. The results shown up to 95% apoptotic (programmed cell death) effect in a number of cancer cell lines incubated during Forty-eight hours. Furthermore, the case study revealed a synergistic impact with traditional chemotherapy treatments.
Petlife expects that Escozine for PetsTM may even extend the life of pets affected by cancer and improve their standard of living. Early findings from veterinary initiated clinical observation research indicates encouraging findings. Petlife reports there has been a noticeable increase in the caliber of life as well as an extension of life over and above the life span anticipated for each pet in the study.
This content in this report is provided for informational reasons only. Entourage Media Ltd. has compensated the creator five-thousand dollars for a Six week seo marketing and advertising awareness service for PetLife Pharmaceuticals. Please consult with a certified financial consultant prior to making any investment decisions pertaining to any corporation mentioned herein.